13 November 2020
Paediatricians, health visitors and GPs have joined forces to produce guidance for parents who are worried about their new baby.
2 October 2020
An interim clinical commissioning policy has been in place across the UK since 3 July 2020, defining routine access to remdesivir in the treatment of COVID-19 in adults and children aged 12 years or older. However, due to increased demand against available supply, clinicians are now asked to apply t...
9 September 2020
Following recent publication of the REMAP-CAP trial for hydrocortisone and a meta-analysis of corticosteroids, the World Health Organization (WHO) has recently issued new interim guidance recommending the use of systemic corticosteroids in severe and critical COVID-19 disease.
1 August 2020
We look ahead to plans for digital growth charts, which will be available to parents and carers in 2021.
24 July 2020
We respond to the government's announcement of this year's flu vaccination programme, which includes Year 7 for the first time.
7 July 2020
Dr Karen Street, Assistant Officer for Mental Health and Wellbeing, responds to a new BMA report which considers the impact of COVID-19 on mental health.
26 June 2020
Ranitidine products (Brand names including Zantac®) were voluntarily withdrawn by manufacturers in October 2019, because of fears that they may contain low levels of an impurity called NMDA.
16 June 2020
Changes have been made to our Child Protection Companion's chapter 9, ''Recognition of physical abuse' to accommodate suggested amendments by the British Paediatric and Adolescent Bone Group on the timing of blood investigations for fractures.
Health Visitors and Paediatricians publish advice for parents about the six-week postnatal check during COVID-19
1 May 2020
The Institute for Health Visiting and RCPCH have published advice for parents who may not be able to attend the six week check for newborn babies.
17 March 2020
The RCPCH/NPPG Medicines Committee has recently been informed of a severe adverse reaction in a six-month old child with anisocoria who had been administered apraclonidine 1% to help exclude Horner syndrome.